Tolerance Bio
Latest round
- Seed
Last raised
- Dec 2024
Total raised
- $32M
Investors
- 6
About Tolerance Bio
Founded in 2023 and based in Pennsylvania, US, Tolerance Bio, Inc. operates as a biotechnology company that focuses on the enhancement of healthspan by targeting the thymus, an organ crucial for immune system function. In December 2024, Tolerance Bio, Inc. Tolerance Bio specializes in developing therapies to restore and manipulate thymic function for treating immune-mediated diseases, including cancer, autoimmune disorders, transplant rejection, and infections. The company focuses on the thymus, a key organ for immune tolerance, and creates therapies to restore or preserve its function, improving immune health and longevity. Thymic dysfunction, which occurs with aging or certain medical treatments, contributes to immune-related diseases. Tolerance Bio's innovative, multi-platform approach includes stem cell-derived thymic epithelial cells, thymic organoids, and therapeutics designed to delay thymic involution, enhancing immune system function and reducing disease risk.
Who invested in Tolerance Bio
6 investors across 2 rounds
See all investors in Tolerance Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tolerance Bio
Who invested in Tolerance Bio?
Tolerance Bio has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tolerance Bio raised?
Tolerance Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Tolerance Bio last raise money?
Tolerance Bio's most recent round on record is a Seed, in Dec 2024.
What does Tolerance Bio do?
Founded in 2023 and based in Pennsylvania, US, Tolerance Bio, Inc.
Where is Tolerance Bio headquartered?
Tolerance Bio is headquartered in Philadelphia, US.
Which VCs invest in companies like Tolerance Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tolerance Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Tolerance Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.